Q2 EPS Forecast for Enliven Therapeutics Reduced by Analyst
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) – Investment analysts at HC Wainwright lowered their Q2 2025 EPS estimates for shares of Enliven Therapeutics in a research note issued on Thursday, May 15th. HC Wainwright analyst R. Burns now anticipates that the company will post earnings per share of ($0.60) for the quarter, down from […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) – Investment analysts at HC Wainwright lowered their Q2 2025 EPS estimates for shares of Enliven Therapeutics in a research note issued on Thursday, May 15th. HC Wainwright analyst R. Burns now anticipates that the company will post earnings per share of ($0.60) for the quarter, down from […]
